Lupus treatment generates positive results in Phase III clinical trial

(Wiley) New research indicates that belimumab, a monoclonal antibody therapy that targets a component of the immune system, provides considerable benefits to patients with systemic lupus erythematosus (SLE), a predominately female, chronic inflammatory disease that can affect virtually any organ.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news